SCHEMBL30667773

SCHEMBL30667773

Cn1nccc1-c1cc(Cl)nc(C(N)=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ PI4KA P42356 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ PI4KB Q9UBF8 1/20 0.39
▸ SCN9A Q15858 6/20 0.39
▸ PKMYT1 Q99640 1/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ SLC13A5 Q86YT5 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ ABL1 P00519 1/20 0.37
▸ P2RX7 Q99572 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ PIM1 P11309 2/20 0.37
▸ PIM3 Q86V86 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26863020 1.00 LMNA (0.40) LMNAALDH1A1MAPTPIK3CDPIK3CA
SCHEMBL16505765 0.78 LMNA (0.51) LMNAALDH1A1MAPTSCN9APIM1
SCHEMBL28051826 0.72 SCN9A (0.53) SCN9AALOX5SLC13A5JAK1JAK3
SCHEMBL26684723 0.71 LMNA (0.42) LMNASCN9APIM1PIM3PIM2
SCHEMBL31507488 0.71 LMNA (0.42) LMNASCN9APIM1PIM3PIM2
SCHEMBL28051827 0.70 SCN9A (0.39) ALDH1A1MAPTSCN9AALOX5JAK1
SCHEMBL3662335 0.70 FYN (0.47) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL18422297 0.69 ALDH1A1 (0.44) ALDH1A1MAPTPIK3CDPIK3CAPIK3CB
SCHEMBL3344435 0.69 PKMYT1 (0.47) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL17130073 0.69 HAVCR2 (0.40) ALDH1A1MAPTABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-09-11 — — US disclosed
EP-4522608-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2025-03-19 — — EP disclosed
CN-119546602-A Pyrrolidone derivatives as inhibitors of nfkb-induced kinase 詹森药业有限公司 2025-02-28 — — CN disclosed
WO-2023217906-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB LMNA 2373/4885ALDH1A1 4167/4885MAPT 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback